Mirati Therapeutics, Inc. (MRTX) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Mirati Therapeutics, Inc., with annual and quarterly history.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -3.44x | -13.08x | -27.61x | -22.64x | -13.32x | -6.55x |
| P/B Ratio | 2.56x | 5.45x | 7.26x | 12.63x | 6.50x | 3.22x |
| P/S Ratio | 204.88x | 105.57x | 737.51x | 1447.71x | 101.40x | 0.00x |
| Profitability | ||||||
| Gross Margin | 95.2% | -605.5% | -2134.3% | -5383.2% | -626.2% | 0.0% |
| Operating Margin | -6108.0% | -795.1% | -2756.9% | -6659.8% | -794.0% | 0.0% |
| Net Margin | -5957.4% | -807.0% | -2671.6% | -6394.5% | -761.4% | 0.0% |
| EBITDA Margin | -6084.4% | -792.6% | -2752.1% | -6652.3% | -794.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 6.96x | 10.50x | 19.64x | 8.68x | 8.67x | 11.42x |
| Quick Ratio | 6.94x | 10.51x | 19.67x | 8.71x | 8.70x | 11.43x |
| Leverage | ||||||
| Debt/Equity | 0.05x | 0.03x | 0.03x | 0.00x | 0.00x | 0.00x |
YoY = year-over-year change. Source: FMP..